BMS 754807: Clinical Trials

7 trials of BMS 754807, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Terminated 1
Phase 23Terminated 2, Completed 1

Follow BMS 754807: new trials by email Literature Review of BMS 754807 trials Research Report on BMS 754807

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin
BMS-754807 (IGR-IR/IR Inhibitor), Metformin - Healthy Volunteers
Phase 1CompletedBristol-Myers Squibb262012-02-012012-06-14
Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
BMS-754807, letrozole - Breast Cancer
Phase 2TerminatedBristol-Myers Squibb772010-12-312020-08-11
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
BMS-754807, cetuximab (Erbitux®) - Colorectal Cancer, Head and Neck Cancer
Phase 1 / Phase 2TerminatedBristol-Myers Squibb542009-10-012013-06-18
Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan
BMS-754807 - Neoplasms
Phase 1CompletedBristol-Myers Squibb152009-09-012011-11-30
Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer
BMS-754807, trastuzumab (Herceptin®) - Breast Cancer
Phase 1 / Phase 2CompletedBristol-Myers Squibb402009-07-012012-07-13
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors
BMS-754807, Paclitaxel, Carboplatin - Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1CompletedBristol-Myers Squibb212009-04-012012-07-13
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors
BMS-754807 - Neoplasms, Solid Tumors
Phase 1CompletedBristol-Myers Squibb632008-04-012013-08-14

Conditions studied

Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Colorectal Neoplasms (1)  ·  Head and Neck Neoplasms (1)

Sponsors

Bristol-Myers Squibb (7)

Countries

Australia (4)  ·  Canada (3)  ·  United States (2)  ·  Belgium (1)  ·  Hungary (1)  ·  Japan (1)  ·  South Korea (1)  ·  United Kingdom (1)